Emergent Biosolutions, Inc. (NYSE: EBS)
$10.3050
-0.0150 ( +0.49% ) 6.5K
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Market Data
Open
$10.3050
Previous close
$10.3200
Volume
6.5K
Market cap
$559.18M
Day range
$10.1600 - $10.6650
52 week range
$1.4200 - $15.1000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jul 12, 2024 |
| 8-k | 8K-related | 13 | Jul 12, 2024 |
| 4 | Insider transactions | 1 | Jul 12, 2024 |
| 4 | Insider transactions | 1 | Jul 10, 2024 |
| 8-k | 8K-related | 13 | Jul 08, 2024 |
| 8-k | 8K-related | 22 | Jul 02, 2024 |
| 8-k | 8K-related | 15 | Jun 20, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |